In vitro oogenesis: How far have we come?

被引:0
|
作者
Arkoun, B. [1 ]
Livera, G. [1 ]
机构
[1] Univ Paris Saclay, Univ Paris Sud,Lab Dev Gonades,Inserm, Sorbonne Paris Cite,Unite Stabilite Genet Cellule, Univ Paris Diderot,CEA DRF iRCM SCSR,UMR 967, F-92265 Fontenay Aux Roses, France
来源
关键词
Oogenesis; ESC/iPSC; PGC-LC; In vitro; PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; SPECIFICATION; INDUCTION; CULTURE; OOCYTES; RECONSTITUTION; FATE; BMP4;
D O I
10.1016/j.gofs.2017.11.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Oogenesis is a complex cellular and molecular process whose fundamental mechanisms are still poorly described or not yet elucidated, especially in human species. The development of an in vitro model of oogenesis, particularly during fetal development in humans, is a critical step that would allow: (i) a better understand of the biological mechanisms of oogenesis; (ii) a refinement of medical diagnosis for women suffering from infertility; and (iii) providing new therapeutics for reproductive pathologies. The genesis of this model could be considered from ES/iPS cells. In this article, we will trace the physiological mechanisms of oogenesis in vivo and discuss the studies carried out in the field of in vitro oogenesis from ES/iPS cells, as well as the challenges to be met in the future. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [41] THE TOBACCO EPIDEMIC - HOW FAR HAVE WE COME
    WALKER, JD
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1993, 148 (02) : 145 - 147
  • [42] Improving adherence: how far have we come?
    Henderson, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S590 - S590
  • [43] Allopurinol to Febuxostat: How far have we come?
    Stockert, Amy L. d
    Stechschulte, Melissa
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 927 - 945
  • [44] How far have we come in Earth systemscience?
    Kasting, James F.
    EARTHS FUTURE, 2013, 1 (01) : 42 - 44
  • [45] Team rewards: How far have we come?
    McClurg, LN
    HUMAN RESOURCE MANAGEMENT, 2001, 40 (01) : 73 - 86
  • [46] Language Screening: How Far Have We Come?
    Longerbeam, Marsha S.
    Freeman, Linda M.
    CURRENT DEVELOPMENTAL DISORDERS REPORTS, 2020, 7 (03) : 116 - 123
  • [47] Women and the economy: how far have we come?
    Casale, Daniela
    Posel, Dorrit
    AGENDA-EMPOWERING WOMEN FOR GENDER EQUITY, 2005, 19 (64): : 21 - 29
  • [48] Multiple myeloma: How far have we come?
    Anderson, KC
    MAYO CLINIC PROCEEDINGS, 2003, 78 (01) : 15 - 17
  • [49] Phytic acid: How far have we come?
    Ali, Muhammad
    Shuja, Malik Nawaz
    Zahoor, Muhammad
    Qadri, Ishtiaq
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (11): : 1551 - 1554
  • [50] RE progress: How far have we come?
    Refocus, 2002, 3 (04): : 30 - 32